First Time Loading...

Alpine Immune Sciences Inc
NASDAQ:ALPN

Watchlist Manager
Alpine Immune Sciences Inc Logo
Alpine Immune Sciences Inc
NASDAQ:ALPN
Watchlist
Price: 64.56 USD -0.09% Market Closed
Updated: Apr 28, 2024

Income Statement

Earnings Waterfall
Alpine Immune Sciences Inc

Revenue
58.9m USD
Operating Expenses
-103.1m USD
Operating Income
-44.3m USD
Other Expenses
12.1m USD
Net Income
-32.2m USD

Income Statement
Alpine Immune Sciences Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
3
N/A
4
+25%
4
+20%
5
+3%
2
-62%
1
-24%
1
-27%
1
-13%
1
-15%
0
-45%
1
+46%
1
+51%
2
+102%
3
+63%
3
+4%
5
+55%
9
+104%
11
+22%
18
+57%
25
+37%
23
-5%
34
+44%
32
-6%
32
0%
30
-6%
26
-14%
29
+13%
31
+6%
59
+91%
Operating Income
Operating Expenses
(15)
(14)
(14)
(16)
(20)
(1)
(27)
(29)
(31)
(4)
1
5
8
(17)
(13)
(23)
(31)
(37)
(45)
(49)
(49)
(45)
(39)
(37)
(34)
(38)
(45)
(53)
(65)
(73)
(81)
(85)
(85)
(88)
(92)
(95)
(97)
(103)
Selling, General & Administrative
(2)
(2)
(3)
(4)
(5)
(0)
(8)
(9)
(9)
(1)
0
0
0
(6)
(7)
(7)
(7)
(8)
(9)
(9)
(10)
(9)
(9)
(10)
(10)
(11)
(12)
(12)
(13)
(15)
(16)
(17)
(18)
(18)
(19)
(19)
(20)
(22)
Research & Development
(13)
(12)
(11)
(12)
(15)
(0)
(19)
(21)
(22)
(3)
1
5
8
(11)
(13)
(16)
(24)
(29)
(36)
(40)
(39)
(36)
(30)
(27)
(24)
(27)
(33)
(40)
(52)
(59)
(65)
(68)
(67)
(70)
(74)
(75)
(77)
(81)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
(15)
N/A
(14)
+2%
(14)
+1%
(16)
-13%
(20)
-21%
(0)
+98%
(27)
-7 065%
(29)
-10%
(31)
-5%
(1)
+96%
5
N/A
10
+104%
13
+31%
(15)
N/A
(12)
+20%
(22)
-85%
(30)
-35%
(37)
-22%
(45)
-23%
(49)
-8%
(48)
+1%
(44)
+9%
(36)
+16%
(34)
+7%
(29)
+14%
(29)
+2%
(34)
-17%
(35)
-3%
(41)
-18%
(50)
-22%
(47)
+6%
(53)
-12%
(53)
-1%
(58)
-9%
(66)
-14%
(65)
+1%
(66)
-1%
(44)
+33%
Pre-Tax Income
Interest Income Expense
(1)
(1)
(1)
(0)
0
0
0
0
0
0
(0)
(0)
(0)
0
1
1
1
1
1
1
1
1
1
0
(0)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
1
3
5
7
10
12
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
7
7
0
5
(1)
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
2
1
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
Pre-Tax Income
(15)
N/A
(15)
+4%
(15)
+0%
(16)
-11%
(20)
-21%
(0)
+98%
(26)
-7 019%
(29)
-10%
(30)
-5%
(1)
+96%
5
N/A
10
+104%
19
+100%
(8)
N/A
(11)
-42%
(16)
-40%
(30)
-90%
(37)
-22%
(44)
-19%
(48)
-8%
(47)
+1%
(42)
+11%
(35)
+16%
(33)
+6%
(28)
+16%
(28)
-1%
(33)
-18%
(34)
-3%
(41)
-21%
(50)
-22%
(47)
+6%
(53)
-11%
(53)
+0%
(55)
-5%
(61)
-10%
(58)
+5%
(56)
+3%
(32)
+43%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
1
1
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
(2)
(1)
(2)
(2)
(1)
(1)
(0)
Income from Continuing Operations
(15)
(15)
(15)
(16)
(20)
(0)
(26)
(29)
(30)
(1)
5
10
19
(8)
(11)
(15)
(30)
(36)
(44)
(48)
(47)
(42)
(35)
(33)
(28)
(28)
(33)
(34)
(42)
(50)
(47)
(54)
(54)
(58)
(64)
(59)
(57)
(32)
Net Income (Common)
(15)
N/A
(15)
+4%
(15)
+0%
(16)
-11%
(20)
-21%
(0)
+98%
(26)
-7 019%
(29)
-10%
(30)
-5%
(1)
+96%
5
N/A
10
+106%
19
+101%
(8)
N/A
(11)
-43%
(15)
-39%
(30)
-92%
(36)
-23%
(44)
-19%
(48)
-9%
(47)
+1%
(42)
+11%
(35)
+16%
(33)
+6%
(28)
+16%
(28)
-1%
(33)
-18%
(34)
-3%
(42)
-22%
(50)
-21%
(47)
+6%
(54)
-15%
(54)
+0%
(58)
-7%
(64)
-10%
(59)
+8%
(57)
+3%
(32)
+44%
EPS (Diluted)
-4.56
N/A
-4.37
+4%
-4.37
N/A
-4.21
+4%
-5.11
-21%
-0.74
+86%
-6.82
-822%
-7.5
-10%
-7.81
-4%
-2.18
+72%
7.1
N/A
14.17
+100%
1.8
-87%
-1.2
N/A
-0.8
+33%
-1.11
-39%
-2.14
-93%
-2.63
-23%
-2.46
+6%
-2.55
-4%
-2.52
+1%
-2.28
+10%
-1.89
+17%
-1.78
+6%
-1.24
+30%
-1.34
-8%
-1.38
-3%
-1.42
-3%
-1.67
-18%
-1.98
-19%
-1.55
+22%
-1.79
-15%
-1.71
+4%
-1.73
-1%
-1.33
+23%
-1.21
+9%
-1.15
+5%
-0.64
+44%

See Also

Discover More